VEGFA and age-related macular degeneration: For this purpose, survival analysis was performed and Kaplan–Meier survival curve revealed that at 12 months anti-VEGF treatment can provide 64% symptomatic recovery from AMD, while at 36 months, it was only 25% (Fig. 5).